E. Csinady

发表

Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The ‘big sister’ of the infant disease?

M. Schrappe, J. Dongen, H. Gadner, 2007, Leukemia.

R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes

L. Sehn, B. Coiffier, M. Pfreundschuh, 2014, Haematologica.

Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.

M. König, J. Harbott, O. Haas, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chromosome 14 copy number-dependent IGH gene rearrangement patterns in high hyperdiploid childhood B-cell precursor ALL: implications for leukemia biology and minimal residual disease analysis

M. König, O. Haas, J. Dongen, 2009, Leukemia.

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect

A. Dupuy, O. Dereure, M. Richard, 2019, The British journal of dermatology.